Your browser doesn't support javascript.
loading
The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
Mustafa, S; Martin, H L; Burkly, L; Costa, A; Martins, M L; Schwaninger, M; Teismann, P.
Afiliación
  • Mustafa S; School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Martin HL; School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Burkly L; Department of Immunology, Biogen Idec, Inc., Cambridge, MA, United States.
  • Costa A; Cell Death Regulation Laboratory, MRC Toxicology Unit, Leicester, United Kingdom.
  • Martins ML; Cell Death Regulation Laboratory, MRC Toxicology Unit, Leicester, United Kingdom.
  • Schwaninger M; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany; Department of Pharmacology, University of Heidelberg, Germany.
  • Teismann P; School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: pteismann@gmx.de.
Neuroscience ; 319: 116-22, 2016 Apr 05.
Article en En | MEDLINE | ID: mdl-26808775

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores del Factor de Necrosis Tumoral / Trastornos Parkinsonianos / Factores de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male Idioma: En Revista: Neuroscience Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores del Factor de Necrosis Tumoral / Trastornos Parkinsonianos / Factores de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male Idioma: En Revista: Neuroscience Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos